SCHEMBL5505536

SCHEMBL5505536

O=CCCc1ccc(Sc2cccc(OCc3ccccc3)c2)cc1Cl

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
S1PR1 P21453 3/20 0.58
MAOB P27338 5/20 0.45
MAOA P21397 1/20 0.45
CCNB2 O95067 1/20 0.42
CDK1 P06493 1/20 0.42
CDK4 P11802 1/20 0.42
CCNB1 P14635 1/20 0.42
CCND1 P24385 1/20 0.42
CCNB3 Q8WWL7 1/20 0.42
BCHE P06276 3/20 0.40
CYP4F2 P78329 1/20 0.40
CYP4A11 Q02928 1/20 0.40
PRKX P51817 1/20 0.40
ACVR1 Q04771 1/20 0.40
S1PR5 Q9H228 1/20 0.40
NR4A2 P43354 1/20 0.40
KDM4E B2RXH2 1/20 0.39
ALDH1A1 P00352 1/20 0.39
PKM P14618 1/20 0.39
LCK P06239 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1563170 0.91 S1PR1 (0.48) S1PR1MAOBMAOABCHEPRKX
SCHEMBL1563615 0.89 S1PR1 (0.55) S1PR1MAOBMAOACCNB2CDK1
SCHEMBL5505756 0.85 S1PR1 (0.63) S1PR1MAOBBCHECYP4F2CYP4A11
SCHEMBL1563997 0.85 S1PR1 (0.58) S1PR1MAOBMAOABCHECYP4F2
SCHEMBL16355892 0.84 S1PR1 (0.52) S1PR1MAOBMAOACCNB2CDK1
SCHEMBL13265616 0.84 S1PR1 (0.60) S1PR1MAOBMAOACCNB2CDK1
SCHEMBL13285272 0.84 S1PR1 (0.60) S1PR1MAOBMAOACCNB2CDK1
SCHEMBL1563640 0.83 S1PR1 (0.56) S1PR1MAOBMAOABCHECYP4F2
SCHEMBL1564052 0.83 S1PR1 (0.61) S1PR1MAOBBCHECYP4F2CYP4A11
SCHEMBL13265617 0.83 S1PR1 (0.56) S1PR1MAOBMAOACCNB2CDK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1431284-B1 DIARYL SULFIDE DERIVATIVE, ADDITION SALT THEREOF, AND IMMUNOSUPPRESSANT KYORIN SEIYAKU KK (JP) 2007-11-21 EP disclosed
US-6960692-B2 2-amino-2-[4-(3-benzyloxyphenylthio)-2-chlorophenyl]propyl-1,3-propanediol; autoimmune diseases, rheumatoid arthritis, psoriasis, dermatitis, asthma, hay fever, anti-rejection of organ or bone marrow transplants; side effect reduction KYORIN PHARMACEUTICAL CO., LTD. (JP) 2005-11-01 US disclosed
US-20040254222-A1 Diaryl sulfide derivative, addition salt thereof, and immunosuppressant PRIOTHERA LIMITED (IE) 2004-12-16 US disclosed
EP-1431284-A1 DIARYL SULFIDE DERIVATIVE, ADDITION SALT THEREOF, AND IMMUNOSUPPRESSANT Kyorin Pharmaceutical Co., Ltd. (JP) 2004-06-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040254222-A1 Diaryl sulfide derivative, addition salt thereof, and immunosuppressant TST, IL2, CBS S1PR1 993/4885MAOB 4319/4885MAOA 4639/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.